← All trials
NCT00088452
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2004
- Primary completion
- Jan 1, 2013
- Completion date
- Aug 31, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 453
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of CincinnatiLead sponsor
- University of PennsylvaniaOverall official - principal investigator
- University of CincinnatiOverall official - principal investigator
- Children's National Medical CenterOverall official - principal investigator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.